Pediatric Insomnia.

This review explains that sleep problems are very common in children, especially those with autism or ADHD. Children may have trouble falling asleep, staying asleep, or both. The best treatment is a type of counseling called cognitive behavioral therapy for insomnia (CBT-I). Melatonin can help children with autism or ADHD sleep better.

It's important to treat sleep problems early because they can become long-term issues that affect a child's mental health and quality of life. Doctors should also check for other conditions that might be causing sleep problems.

This review examines pediatric insomnia, a common condition involving difficulty falling or staying asleep that significantly impacts well-being. The prevalence is notably higher in children with autism spectrum disorder (ASD) or ADHD. Two main subtypes are identified: behavioral insomnia and psychophysiological insomnia. The review emphasizes the importance of pediatricians being familiar with diagnosis and management, as clinical symptoms are often subtle.

Differential diagnosis should exclude underlying conditions like sleep apnea, anxiety, or other medical disorders. Cognitive behavioral therapy for insomnia (CBT-I) is identified as the most effective treatment. While melatonin shows benefits for children with autism or ADHD, further research is needed for other pharmacological options. Early intervention is crucial to prevent chronic insomnia and its negative effects on mental health and quality of life.

Clinicians should routinely screen for sleep problems in children with autism or ADHD. CBT-I should be considered first-line treatment. Melatonin may be beneficial for children with autism or ADHD. Comprehensive assessment should exclude underlying medical conditions. Early intervention is important to prevent chronic insomnia and its negative impacts on mental health and quality of life.

This is a narrative review without systematic methodology. No sample size or specific studies are reported. The abstract lacks details about the evidence base underlying the recommendations. The strength of evidence for treatment recommendations is unclear.

Pediatric insomnia is a common condition that can significantly impact a patient's well-being. It typically involves difficulty falling asleep, staying asleep, or both. The prevalence of insomnia is notably higher among children with autism spectrum disorder (ASD) or attention-deficit hyperactivity disorder (ADHD). Two commonly recognized subtypes of pediatric insomnia are behavioral insomnia and psychophysiological insomnia.

Because clinical symptoms and physical examination findings are often subtle, pediatricians should be familiar with the diagnosis and management of insomnia. Pediatricians should also consider and rule out underlying disorders such as sleep apnea, anxiety, or other medical conditions that may contribute to or mimic insomnia. Cognitive behavioral therapy for insomnia (CBT-I) is currently regarded as the most effective treatment. While melatonin has shown benefits in children with autism or ADHD, additional research is needed to evaluate the efficacy of other pharmacologic options.

Timely intervention is crucial, as pediatric insomnia can become chronic and negatively affect mental health and overall quality of life.